SCHEMBL28199847

SCHEMBL28199847

COC(=O)CCCCCCOc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.58
MAPT P10636 6/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
CRHBP P24387 1/20 0.55
CRHR2 Q13324 1/20 0.55
HRH3 Q9Y5N1 1/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
ALDH1A1 P00352 1/20 0.52
BCL9 O00512 1/20 0.51
CTNNB1 P35222 1/20 0.51
KCNH2 Q12809 2/20 0.51
DRD2 P14416 1/20 0.51
DRD4 P21917 1/20 0.51
DRD3 P35462 1/20 0.51
NPC1 O15118 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18689537 1.00 PTGS2 (0.58) PTGS2MAPTL3MBTL1CRHBPCRHR2
SCHEMBL831490 1.00 PTGS2 (0.58) PTGS2MAPTL3MBTL1CRHBPCRHR2
SCHEMBL6336850 0.94 PTGS2 (0.60) PTGS2MAPTL3MBTL1CRHBPCRHR2
SCHEMBL3026910 0.90 PTGS2 (0.62) PTGS2MAPTL3MBTL1CRHBPCRHR2
SCHEMBL16261894 0.87 BCL9 (0.64) MAPTL3MBTL1CRHBPCRHR2HRH3
SCHEMBL4275826 0.86 HDAC1 (0.56) MAPTL3MBTL1KMT2AALDH1A1
SCHEMBL5467715 0.86 MAPT (0.69) PTGS2MAPTL3MBTL1CRHBPCRHR2
SCHEMBL7634106 0.86 HDAC3 (0.63) PTGS2MAPTL3MBTL1CRHBPCRHR2
SCHEMBL7369987 0.85 BCL9 (0.52) PTGS2MAPTL3MBTL1CRHBPCRHR2
SCHEMBL18631907 0.85 BCL9 (0.52) PTGS2MAPTL3MBTL1CRHBPCRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107619407-A Double target spot inhibitor of HDAC and VEGFR based on pazopanib structure and its preparation method and application 山东大学 2018-01-23 CN claimed
CN-107619407-B Bis- target spot inhibitor of HDAC and VEGFR based on pazopanib structure and its preparation method and application 山东大学 2019-05-24 CN disclosed
CN-107619407-A Double target spot inhibitor of HDAC and VEGFR based on pazopanib structure and its preparation method and application 山东大学 2018-01-23 CN disclosed